NDC 51672-2120-01 - Triple Antibiotic
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 51672-2120
- Requested NDC
- 51672-2120-01
- Package NDCs from labels
- 51672-2120-1, 51672-2120-2, 51672-2120-3, 51672-2120-6, 51672-2120-8, 51672-2120-9, 51672-2120-01
- Manufacturer
- NuCare Pharmaceutical, Inc.
- Effective date
- 2026-09-09
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Triple Antibiotic | NuCare Pharmaceutical, Inc. | 2026-09-09 | HUMAN OTC DRUG LABEL |
| Triple Antibiotic | Sun Pharmaceutical Industries, Inc. | Sun Pharma Canada Inc. | GOPALDAS VISRAM AND COMPANY LIMITED | 2026-06-02 | HUMAN OTC DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 51672-2120-1 | Triple Antibiotic | 1 in 1 CARTON | OINTMENT | 1 | 5 | |
| 51672-2120-1 | Triple Antibiotic | 14.2 g in 1 TUBE | OINTMENT | 14.2 | 5 | |
| 51672-2120-2 | Triple Antibiotic | 1 in 1 CARTON | OINTMENT | 1 | 5 | |
| 51672-2120-2 | Triple Antibiotic | 28.4 g in 1 TUBE | OINTMENT | 28.4 | 5 | |
| 51672-2120-3 | Triple Antibiotic | 60 g in 1 TUBE | OINTMENT | 60 | 5 | |
| 51672-2120-3 | Triple Antibiotic | 1 in 1 CARTON | OINTMENT | 1 | 5 | |
| 51672-2120-6 | Triple Antibiotic | 0.9 g in 1 APPLICATOR | OINTMENT | 0.9 | 5 | |
| 51672-2120-6 | Triple Antibiotic | 6 in 1 CARTON | OINTMENT | 6 | 5 | |
| 51672-2120-8 | Triple Antibiotic | 0.9 g in 1 APPLICATOR | OINTMENT | 0.9 | 5 | |
| 51672-2120-8 | Triple Antibiotic | 15 in 1 CARTON | OINTMENT | 15 | 5 | |
| 51672-2120-9 | Triple Antibiotic | 144 in 1 CARTON | OINTMENT | 144 | 5 | |
| 51672-2120-9 | Triple Antibiotic | 0.9 g in 1 APPLICATOR | OINTMENT | 0.9 | 5 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 51672-2120 | TRIPLE ANTIBIOTIC (BACITRACIN ZINC, NEOMYCIN SULFATE, AND POLYMYXIN B SULFATE) OINTMENT [TARO PHARMACEUTICALS U.S.A., INC.] | 4 | Current NDC, Legacy NDC, 12 package rows | 20240427_d77239e6-5e81-439a-b0cd-f8be59169442.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 51672-2120-1 | GM - Gram | 51672-2120 | 161fa1c5-9889-4d4d-b06e-da422f00f3a3 | 1 | 2016-05-16 |
| 51672-2120-2 | GM - Gram | 51672-2120 | 44e5c044-5369-45b0-b1d4-5711f5d65f74 | 1 | 2016-05-16 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Jack Black | AVOBENZONE/HOMOSALATE/OCTISALATE/PETROLATUM | Jack Black L.L.C. | 4babe2ab-c5da-9a83-e063-6294a90aee4c | 2026-02-25 | Warnings | 4T6H12BN9U |
| Jack Black | AVOBENZONE/HOMOSALATE/OCTISALATE/PETROLATUM | Jack Black L.L.C. | 4bac1c33-36fe-8d29-e063-6394a90a32a5 | 2026-02-25 | Warnings | 4T6H12BN9U |
| Jack Black | AVOBENZONE/HOMOSALATE/OCTISALATE/PETROLATUM | Jack Black L.L.C. | 4bac5550-c45f-a738-e063-6394a90ae5c8 | 2026-02-25 | Warnings | 4T6H12BN9U |
| Jack Black | AVOBENZONE/HOMOSALATE/OCTISALATE/PETROLATUM | Jack Black L.L.C. | 4baca374-7aaa-8d1d-e063-6394a90a5a55 | 2026-02-25 | Warnings | 4T6H12BN9U |
| Jack Black | AVOBENZONE/HOMOSALATE/OCTISALATE/PETROLATUM | Jack Black L.L.C. | 4bad1502-bc44-54ec-e063-6294a90ace8b | 2026-02-25 | Warnings | 4T6H12BN9U |
| Neomycin and Polymyxin B Sulfates and Hydrocortisone | NEOMYCIN SULFATE, POLYMYXIN B SULFATE AND HYDROCORTISONE | A-S Medication Solutions | 1185a82b-e731-456a-8fc1-d9f0fc1ab0bc | 2026-02-24 | Warnings, Adverse reactions | 057Y626693 19371312D4 |
| Petroleum Skin Protectant | WHITE PETROLATUM | Family Dollar Stores, Inc | ac7da793-8a39-4b47-b075-a4c4820cadad | 2026-02-24 | Warnings, Adverse reactions | 4T6H12BN9U |
| Advanced Healing | PETROLATUM | Family Dollar Stores, Inc | 7e64a424-afdb-4eb9-b6af-7b8123f1e207 | 2026-02-24 | Warnings, Adverse reactions | 4T6H12BN9U |
| Petroleum Skin Protectant | WHITE PETROLATUM | H E B | e6154e44-d7b2-429c-9bc7-5c064220d3fb | 2026-02-24 | Warnings, Adverse reactions | 4T6H12BN9U |
| Petroleum | WHITE PETROLATUM | H E B | ff79e42c-da3f-4aec-acf4-cc26e10a1d08 | 2026-02-24 | Warnings, Adverse reactions | 4T6H12BN9U |
| Petroleum | WHITE PETROLATUM | H E B | 460802cc-c1b9-41cb-afe3-ca4078175efb | 2026-02-24 | Warnings, Adverse reactions | 4T6H12BN9U |
| Petroleum | WHITE PETROLATUM | H E B | 2dd85211-0840-4d0d-8ba7-ea6184a50942 | 2026-02-24 | Warnings, Adverse reactions | 4T6H12BN9U |
| Petroleum | WHITE PETROLATUM | Meijer, Inc. | 12867b23-b203-4bd7-af6d-efddeead26be | 2026-02-24 | Warnings, Adverse reactions | 4T6H12BN9U |
| Pure petroleum | WHITE PETROLATUM | Better Living Brands, LLC | 75cb8f17-6ef2-403e-ab6e-d8e1e8168ec8 | 2026-02-23 | Warnings, Adverse reactions | 4T6H12BN9U |
| WHITE PETROLATUM | PETROLATUM | Sion Biotext Medical Ltd | 53ca3aeb-1d5d-4964-adb5-1cfa901642da | 2026-02-23 | Warnings | 4T6H12BN9U |
| Advanced Healing | PETROLATUM | Better Living Brands, LLC | ba50f2b2-aff8-42cd-8af0-369060a901fb | 2026-02-23 | Warnings, Adverse reactions | 4T6H12BN9U |
| Petroleum | WHITE PETROLATUM | Perrigo Direct, Inc | e11470b2-80d6-4008-b87e-eb6aeadfce74 | 2026-02-19 | Warnings, Adverse reactions | 4T6H12BN9U |
| Vitamin A D | LANOLIN, PETROLATUM | Meijer, Inc. | adc3bb9b-ed8a-4b65-b44c-1d1e978c89ec | 2026-02-19 | Warnings, Adverse reactions | 4T6H12BN9U |
| Petroleum Skin Protectant | WHITE PETROLATUM | Meijer, Inc. | af293cc0-ccd5-42a6-861b-c19fa6ffd06a | 2026-02-19 | Warnings, Adverse reactions | 4T6H12BN9U |
| Healing for Babies | PETROLATUM | Meijer, Inc. | 09878fe0-0890-4af3-a3f6-d2890041e9f8 | 2026-02-19 | Warnings, Adverse reactions | 4T6H12BN9U |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.